Related references
Note: Only part of the references are listed.Synergy between NMR measurements and MD simulations of protein/RNA complexes: application to the RRMs, the most common RNA recognition motifs
Miroslav Krepl et al.
NUCLEIC ACIDS RESEARCH (2016)
Improvements, trends, and new ideas in molecular docking: 2012-2013 in review
Elizabeth Yuriev et al.
JOURNAL OF MOLECULAR RECOGNITION (2015)
Design, Synthesis and Biological Evaluation of Some Oxadiazole Derivatives as Novel Amide-Based Inhibitors of Soluble Epoxide Hydrolase
Elham Rezaee Zavareh et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2014)
Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors
Stevan Pecic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Latest developments in molecular docking: 2010-2011 in review
Elizabeth Yuriev et al.
JOURNAL OF MOLECULAR RECOGNITION (2013)
Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase
In-Hae Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase
Stevan Pecic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase
Shao-Xu Huang et al.
MEDCHEMCOMM (2012)
Soluble Epoxide Hydrolase Inhibitors and Heart Failure
Hong Qiu et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
R. H. Ingraham et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Structure-Activity Relationships of Cycloalkylamide Derivatives as Inhibitors of the Soluble Epoxide Hydrolase
In-Hae Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Practical Use of Ligand Efficiency Indices Out of the Fragment-Based Approach: Ligand Efficiency-Guided Lead Identification of Soluble Epoxide Hydrolase Inhibitors
Daisuke Tanaka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Outstanding challenges in protein-ligand docking and structure-based virtual screening
Bohdan Waszkowycz et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2011)
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase
Anne B. Eldrup et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N′-diaryl urea inhibitors of soluble epoxide hydrolase
Sampath-Kumar Anandan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Soluble epoxide hydrolase inhibitors: a patent review
Hong C. Shen
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
Tristan E. Rose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors
Hong C. Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors
Sampath-Kumar Anandan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
Anne B. Eldrup et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
John D. Imig et al.
PHARMACEUTICALS (2009)
Insights into the Catalytic Mechanism of Human sEH Phosphatase by Site-Directed Mutagenesis and LC-MS/MS Analysis
Annette Cronin et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase
In-Hae Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids
GA Gomez et al.
PROTEIN SCIENCE (2006)
Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase
KL Tran et al.
BIOCHEMISTRY (2005)
Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility
IH Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations
Y Duan et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Reaction mechanism of soluble epoxide hydrolase: Insights from molecular dynamics simulations
B Schiott et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
A Jakalian et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)
Molecular dynamics simulations of biomolecules
M Karplus et al.
NATURE STRUCTURAL BIOLOGY (2002)
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
BB Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA
JM Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
Epoxide hydrolases: biochemistry and molecular biology
AJ Fretland et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase
T Yamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Modification of the generalized Born model suitable for macromolecules
A Onufriev et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2000)
Share Paper
